Drug intelligence / Profile preview

thioperamide

Development stage
Preclinical
Lead developer
Inserm
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Thioperamide is a potent, selective, and blood-brain barrier-permeable antagonist and inverse agonist of the histamine H3 receptor (H3R). Originally characterized in the late 1980s, it serves as a prototypical pharmacological tool for studying the histaminergic system. By blocking H3 autoreceptors on histaminergic neurons, thioperamide prevents feedback inhibition, thereby increasing the synthesis and release of histamine in the central nervous system. It also acts on H3 heteroreceptors to modulate the release of other neurotransmitters, including acetylcholine, dopamine, and noradrenaline. Preclinical research has demonstrated that thioperamide can rescue circadian rhythm disruptions, improve memory consolidation (such as novel object recognition), and enhance wakefulness in animal models of neurodegenerative and sleep disorders, including Parkinson's disease and Alzheimer's disease.

Other names
thioperamide maleate
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)HRH3 (Histamine Receptor H3)Cyp (Cyclophilin family)σR (Sigma receptors)

Beyond the preview

Go deeper on thioperamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thioperamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call